跳至主要内容
临床试验/CTRI/2019/01/017128
CTRI/2019/01/017128招募中未知

A Prospective, obseRvational, multicenter study to evaluate safety and efficacy of fix dOse combination of Metformin, glimePiride, and voglibose in Type 2 diabetes mellitus patients

Aprica Healthcare Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1.Patients willing to provide written informed consent at the time of enrolment
  • 2.Male or Female patients above 18 years
  • 3.Patients suffering from type 2 diabetes mellitus
  • 4.Patients treated with fixed dose combination metformin, glimepiride and voglibose

排除标准

  • 1.Patients receiving any other antidiabetic agent other than mentioned in inclusion criteria
  • 2.Patients suffering from any other type of Diabetes except Type 2 diabetes mellitus

研究者

发起方
Aprica Healthcare Pvt Ltd

相似试验